CRELD2 and metabolic dysfunction-associated steatotic liver disease: These results indicate that CRELD2 exhibits a sex-specific function during NAFLD in humans, and upregulated CRELD2 expression in the liver is likely associated with a decrease in serum CRELD2 concentration, which is presumably associated with progression to NASH in male patients.